MAC
Mason & Associates (California) Portfolio holdings
AUM
$497M
1-Year Est. Return
17.41%
1 Year Est. Return
+17.41%
AUM
$497M
AUM Growth
+$63.4M
(+15%)
Holding
140
Top Buys
| 1 | +$7.16M | |
| 2 | +$6.55M | |
| 3 | +$5.65M | |
| 4 |
Pacer US Large Cap Cash Cows Growth Leaders ETF
COWG
|
+$5.3M |
| 5 |
Avantis Emerging Markets Equity ETF
AVEM
|
+$3.84M |
Top Sells
| 1 | +$11.7M | |
| 2 | +$3.01M | |
| 3 | +$2.81M | |
| 4 |
Snowflake
SNOW
|
+$562K |
| 5 |
ASML
ASML
|
+$523K |
Sector Composition
| 1 | Technology | 9.33% |
| 2 | Financials | 3.66% |
| 3 | Consumer Discretionary | 2.72% |
| 4 | Communication Services | 2.25% |
| 5 | Healthcare | 1.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Mobileye
MBLY
$8.23B
| $217K | 0.04% |
+15,400
|
|
||
127
First Citizens BancShares
FCNCA
$26.3B
| $216K | 0.04% |
121
|
|
||
128
Applied Materials
AMAT
$197B
| $215K | 0.04% |
+1,051
|
|
||
129
Southern Company
SO
$95.8B
| $210K | 0.04% |
2,211
|
|
||
130
Corebridge Financial
CRBG
$15.4B
| $201K | 0.04% |
6,278
|
|
||
131
Nuveen ESG International Developed Markets Equity ETF
NUDM
$632M
| $201K | 0.04% |
+5,340
|
|
||
132
Recursion Pharmaceuticals
RXRX
$2.44B
| $162K | 0.03% |
33,165
|
|
||
|
IBO
133
Impact BioMedical
IBO
$46M
| $6.65K | ﹤0.01% |
+10,000
|
|
||
134
Intuitive Surgical
ISRG
$197B
| – | – |
-434
|
|
||
135
Invesco S&P 500 Equal Weight Energy ETF
RSPG
$421M
| – | – |
-40,406
|
|
||
|
136
Snowflake
SNOW
$74B
| – | – |
-2,510
|
|
||
137
Sarepta Therapeutics
SRPT
$2.22B
| – | – |
-11,170
|
|
||
138
Edwards Lifesciences
EW
$49.2B
| – | – |
-2,890
|
|
||
139
SPDR S&P Emerging Markets Small Cap ETF
EWX
$731M
| – | – |
-45,226
|
|
||
140
WisdomTree International Hedged Quality Dividend Growth Fund
IHDG
$2.28B
| – | – |
-259,948
|
|